We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Leptin Soluble Receptor Elisa

By HospiMedica staff writers
Posted on 30 Apr 2003
A new two-site enzyme-linked immunosorbent assay (ELISA) is highly specific for the soluble, extracellular portion of the human leptin receptor, allowing a true measurement of circulating levels without cross-reactivity or interference with leptin.

The one-step assay offers 3.5 hours turn-around-time and is easily automated. More...
There is no detectable cross-reactivity or interference with human recombinant leptin. The assay is suitable for use with serum or plasma. No sample treatment is required and reagents are ready to use.

Leptin has a role in many diverse physiologic processes, especially obesity but also energy homeostasis, inflammation, angiogenesis, hematopoiesis, immune function, and reproduction, according to studies. Leptin circulates either as a free hormone or bound to specific binding proteins, the most abundant being the extracellular portion of the specific leptin receptor. The assay is the product of Diagnostic Systems Laboratories, Inc. (DSL, Webster, TX, USA).




Related Links:
DSL

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Digital X-Ray Detector Panel
Acuity G4
Exam Table
PF400
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.